Liraglutide Dosing Guide: Schedule, Titration & What to Expect Each Week

Introduction

Liraglutide is a once-daily injection. For chronic weight management, the target dose is 3.0 mg daily, reached over five weeks of stepwise titration. For type 2 diabetes, the target dose is up to 1.8 mg daily, reached over a similar but shorter taper.

The titration schedule exists to reduce nausea and vomiting, which are the most common reasons people stop the drug. Going straight to 3.0 mg without titration would make most people too sick to continue. Slower titration than the package insert recommends is common in practice when patients struggle.

This guide covers the standard schedule, when to slow it down, what to expect each week, how to inject, what to do about missed doses, and how dosing differs between Saxenda® (obesity) and Victoza® (diabetes).

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Is the Standard Liraglutide Titration Schedule?

The package-insert titration for Saxenda is a 0.6 mg per week increase over five weeks. Week 1 is 0.6 mg daily, week 2 is 1.2 mg, week 3 is 1.8 mg, week 4 is 2.4 mg, and week 5 onward is 3.0 mg, the maintenance dose for weight management.

Quick Answer: Standard titration: 0.6 mg week 1, 1.2 mg week 2, 1.8 mg week 3, 2.4 mg week 4, 3.0 mg week 5 onward

Each new dose is held for at least one week before increasing. The point is to let the GI tract and brainstem nausea receptors adapt to each step before stressing them with more drug. Patients who tolerate the schedule well typically reach 3.0 mg by week 5 and stay there indefinitely.

For Victoza (diabetes), the titration is shorter: 0.6 mg daily for one week, then 1.2 mg daily. Some patients increase to 1.8 mg daily if needed for glycemic control after another week.

What If Titration Causes Too Many Side Effects?

Slowing the schedule is a normal and reasonable adjustment. Roughly 40% of patients experience nausea during titration, and a smaller share have vomiting, diarrhea, or constipation severe enough to warrant pausing the next step.

A common modified schedule holds each dose for 2 weeks instead of 1. So 0.6 mg for two weeks, 1.2 mg for two weeks, and so on, reaching 3.0 mg by week 10. Some clinicians will hold longer at any given dose if symptoms persist. The maintenance dose for weight management is 3.0 mg, but some patients get meaningful weight loss at 2.4 mg or even 1.8 mg if higher doses are intolerable.

Skipping back a dose if a higher one is intolerable, then re-attempting after a week or two, is also reasonable. There’s no medical penalty for taking longer to reach the maintenance dose.

What Should You Expect During Week 1 on 0.6 Mg?

The first week is usually mild. Many patients notice modest appetite suppression by day 3-5, sometimes earlier. Nausea, if it shows up, is typically light and tied to large or fatty meals.

Weight changes in week 1 are minimal and mostly water-related. The 0.6 mg dose is below the therapeutic threshold for weight loss in trials; it exists to introduce the drug gently. The starter pen for Saxenda contains 18 mg of liraglutide, enough to cover the full first month of titration.

The most common week 1 side effects: mild nausea, headache, slight fatigue, modest reduction in appetite. Injection site reactions like itching or a small bump are possible but usually resolve in a day.

What Should You Expect During Week 2-3 on 1.2-1.8 Mg?

Side effects often peak during weeks 2-3 as the dose increases. Nausea becomes more noticeable for most patients, especially in the first 1-3 days after each step up. Constipation or diarrhea can appear. Appetite suppression strengthens.

Weight loss is usually visible by the end of week 3, with 2-5 pounds lost being typical for patients who tolerate the schedule. Energy levels may dip during this window before stabilizing. Food preferences sometimes shift, with reduced interest in heavy or rich foods being a common report.

If side effects are severe enough that a patient considers stopping, this is the right time to slow titration rather than push through. The drug works just as well at 3.0 mg whether you reach it in 5 weeks or 12.

What Should You Expect During Week 4-5 on 2.4-3.0 Mg?

By the time patients reach 2.4 mg and 3.0 mg, most have adapted to the most pronounced GI effects. Some residual nausea is common, especially with large meals, but it’s usually manageable.

Weight loss accelerates. By week 5 on full dose, total weight loss of 5-10 pounds is common. Hunger is typically much lower than baseline. Meal size decreases, often substantially, without conscious effort. Some patients feel “full” after a third of their usual portion.

The 3.0 mg dose is the maintenance dose for chronic weight management. Most patients stay here indefinitely. There is no approved dose higher than 3.0 mg daily for liraglutide, and trials have not shown additional benefit from pushing past it.

How Do You Inject Liraglutide Correctly?

Liraglutide comes in a pre-filled multi-dose pen. The injection is subcutaneous (under the skin, not into muscle) in the abdomen, thigh, or upper arm. Site rotation each day prevents lipohypertrophy, a thickening of fat tissue from repeated injections in one spot.

The standard technique: pinch a fold of skin, insert the needle at 90 degrees, depress the plunger fully, count to 6, then remove the needle. The pen dial is set to the prescribed dose, and a click confirms the correct setting. Pen needles are single-use and should be discarded in a sharps container.

Time of day matters less than consistency. Pick a daily window (morning, evening, mealtime) and stick with it. Food does not affect absorption, so the injection can happen before, during, or after meals.

What Happens If You Miss a Liraglutide Dose?

If you remember within 12 hours of the usual time, take the dose and resume normal scheduling the next day. If more than 12 hours have passed, skip the missed dose and take the next dose at the regular time. Do not double up.

Missing more than 3 days in a row is enough for tolerance to GI side effects to fade. Restarting after a gap of 3-7 days usually means re-titrating from a lower dose to avoid severe nausea. A gap of more than 14 days typically means restarting from 0.6 mg.

The FDA label specifically advises restarting at 0.6 mg after extended interruption, then re-titrating, because the gastric and brainstem adaptation that develops over weeks of dosing can be lost.

Key Takeaway: The drug should be injected daily in the abdomen, thigh, or upper arm, with site rotation each day

How Is Saxenda Dosing Different From Victoza Dosing?

Same molecule, different doses. Victoza is approved for type 2 diabetes at up to 1.8 mg daily. Saxenda is approved for chronic weight management at 3.0 mg daily. Both use pre-filled multi-dose pens with the same active ingredient, just different dose ranges and labeling.

For diabetes, the LEAD program and clinical practice show most of the glycemic benefit comes by 1.2-1.8 mg. Pushing to 3.0 mg doesn’t add much HbA1c reduction in trials. For weight loss, the SCALE trial showed dose-dependent effect up to 3.0 mg, with the largest weight loss at the highest tested dose.

People taking Victoza for diabetes who want weight loss can sometimes be transitioned to Saxenda, with the dose titrated upward from 1.8 mg to 3.0 mg over a few weeks. This is a common clinical adjustment.

Can You Take Liraglutide with Other Diabetes Medications?

Yes, in many cases. Liraglutide combines safely with metformin, SGLT2 inhibitors, and DPP-4 inhibitors (though combining with DPP-4 inhibitors is generally not recommended since they target the same pathway). Combining with insulin or sulfonylureas requires lower doses of those medications to avoid hypoglycemia, since liraglutide amplifies their effect.

Adjustment is usually done by the prescribing clinician at the time liraglutide is added. Sulfonylureas are often reduced by 25-50%. Basal insulin doses are typically reduced 10-20%. Blood glucose monitoring becomes more useful during transition periods.

For weight management without diabetes, no specific dose adjustments to other medications are usually needed, but interactions with oral medications can occur because of slowed gastric emptying.

What Dose Modifications Are Needed for Kidney or Liver Disease?

No dose adjustment is required based on kidney function alone, including in patients on dialysis, according to the FDA label. The drug is not renally cleared, so kidney impairment doesn’t increase blood levels. Severe kidney disease still warrants caution because of overlapping risks like hypoglycemia and dehydration from GI side effects.

For liver disease, no dose adjustment is needed in mild to moderate impairment. Severe hepatic impairment data are limited. Pharmacokinetics studies show minor changes in exposure with cirrhosis, but clinical significance appears small.

Patients with both diabetes and chronic kidney disease are increasingly given GLP-1 agonists because of the kidney-protective effects shown in trials of newer agents like semaglutide (FLOW, Perkovic et al. 2024 NEJM).

What Blood Tests Are Needed While on Liraglutide?

Routine monitoring on liraglutide is light. Baseline pancreatic enzymes (lipase, amylase) are sometimes drawn but are not required. Routine thyroid function tests aren’t recommended unless symptoms appear.

For diabetes patients, HbA1c at 3-month intervals is standard. For obesity patients without diabetes, periodic glucose and lipid panels are reasonable as part of general metabolic monitoring. Weight, blood pressure, and pulse are usually tracked at each clinical visit.

Symptoms that warrant immediate evaluation include severe abdominal pain (possible pancreatitis), gallbladder symptoms, persistent severe nausea or vomiting with dehydration, and any neck swelling or hoarseness (though thyroid signals in humans have been minimal).

How Long Should You Stay on Liraglutide?

Indefinitely, in most cases. Obesity and type 2 diabetes are chronic conditions, and stopping the medication usually means losing the benefit. Weight regain after stopping GLP-1 drugs is well-documented, with most patients regaining about two-thirds of lost weight within a year.

Some patients cycle off liraglutide temporarily during pregnancy planning (the drug is not recommended during pregnancy) or because of cost or supply issues. Others switch to longer-acting agents like semaglutide. TrimRx works with patients during the free assessment quiz to evaluate fit and develop a personalized treatment plan that accounts for goals, tolerability, and long-term sustainability.

Stopping plans should include a discussion about expected weight regain and strategies for maintaining metabolic improvements.

Bottom line: A missed dose within 12 hours can be taken; beyond that, skip and resume the next day at the regular time

FAQ

What Time of Day Should I Take Liraglutide?

Any time, as long as it’s consistent. Most patients pick morning or evening based on lifestyle. Some find evening injection reduces daytime nausea; others prefer morning so the appetite suppression is strongest at meals. The drug works the same regardless of time. The key is taking it at roughly the same time each day.

Do I Need to Refrigerate the Pen After I Open It?

Once in use, the pen can stay at room temperature (up to 86 F) or in the refrigerator for 30 days. Unused pens stay refrigerated until first use. Never freeze the pen, and discard any pen that has been frozen. Protect from direct light and extreme heat.

Can I Inject in the Same Spot Every Day?

No. Site rotation prevents lipohypertrophy, a thickening of fat tissue that can affect absorption. Rotate among abdomen, thigh, and upper arm, and within each area, shift the exact spot by at least an inch each day. Most patients map out a weekly rotation pattern.

What If I’m Sick on Injection Day?

Take the dose unless you’re vomiting and can’t keep down fluids. If you’re dehydrated, hold the dose and contact your prescriber. Don’t restart after a multi-day pause without checking on whether to re-titrate. Brief illness usually doesn’t require pausing the medication.

Will I Feel the Injection?

Most patients report minimal discomfort. The pen needles are thin (32 gauge typically) and short (4-6 mm). Some sensation is normal, but pain isn’t. Slow, steady injection with the needle inserted at 90 degrees is usually painless.

Can I Drink Alcohol on Liraglutide?

Light to moderate alcohol use is generally compatible. Alcohol can increase nausea, especially on titration weeks, and can lower blood sugar in patients with diabetes. Heavy drinking should be avoided because of pancreatitis risk concerns and potential dehydration from combined GI effects.

What If I Gain Weight on Liraglutide?

Some patients have minimal response, defined in trials as less than 4-5% weight loss at 12-16 weeks on full dose. If weight is rising or flat after 16 weeks at 3.0 mg, options include switching to a more potent GLP-1 (semaglutide, tirzepatide), adding behavioral support, or evaluating other contributors to weight gain like medications, sleep, or hormonal factors. TrimRx can help reassess the plan.

Can I Take Liraglutide If I Have Gastroparesis?

Generally not. Slowed gastric emptying is part of how liraglutide works, and adding it to pre-existing gastroparesis can worsen symptoms severely. Patients with diagnosed gastroparesis should discuss alternatives with their prescriber. Mild or undiagnosed delayed emptying is more common and usually doesn’t preclude use, but baseline GI evaluation may help if symptoms suggest a problem.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.